ATE142262T1 - Gegen das menschliche immunschwäche-virus gerichtetes immunpräparat - Google Patents
Gegen das menschliche immunschwäche-virus gerichtetes immunpräparatInfo
- Publication number
- ATE142262T1 ATE142262T1 AT92109072T AT92109072T ATE142262T1 AT E142262 T1 ATE142262 T1 AT E142262T1 AT 92109072 T AT92109072 T AT 92109072T AT 92109072 T AT92109072 T AT 92109072T AT E142262 T1 ATE142262 T1 AT E142262T1
- Authority
- AT
- Austria
- Prior art keywords
- directed against
- deficiency virus
- human immuno
- immuno deficiency
- immune preparation
- Prior art date
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 230000003472 neutralizing effect Effects 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 238000004458 analytical method Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4216—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
- C07K16/4225—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig against anti-HIV Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3129224A JPH0570493A (ja) | 1991-05-31 | 1991-05-31 | ヒト免疫不全ウイルス(hiv)関連免疫調製物 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE142262T1 true ATE142262T1 (de) | 1996-09-15 |
Family
ID=15004222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92109072T ATE142262T1 (de) | 1991-05-31 | 1992-05-29 | Gegen das menschliche immunschwäche-virus gerichtetes immunpräparat |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0516135B1 (de) |
JP (1) | JPH0570493A (de) |
KR (1) | KR920021164A (de) |
AT (1) | ATE142262T1 (de) |
AU (1) | AU659839B2 (de) |
CA (1) | CA2069671A1 (de) |
DE (1) | DE69213325T2 (de) |
DK (1) | DK0516135T3 (de) |
ES (1) | ES2094252T3 (de) |
GR (1) | GR3021618T3 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2730493B1 (fr) * | 1995-02-09 | 1997-04-18 | Pasteur Institut | Polypeptides de glycoproteine transmembranaire d'enveloppe du retrovirus humain du type hiv-1 et polypeptides presentant avec eux une parente immunologique |
US5843882A (en) | 1995-04-27 | 1998-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides |
US6780847B2 (en) | 1995-04-27 | 2004-08-24 | The United States Of America As Represented By The Department Of Health And Human Services | Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
US6428790B1 (en) | 1995-04-27 | 2002-08-06 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
US6987096B1 (en) | 1995-04-27 | 2006-01-17 | The United States Of America As Represented By The Department Of Health And Human Services | Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof |
US7048935B2 (en) | 1995-04-27 | 2006-05-23 | The United States Of America As Represented By The Department Of Health And Human Services | Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
US6193982B1 (en) | 1995-04-27 | 2001-02-27 | The United States Of America As Represented By The Department Of Health & Human Services | Anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120 |
IT1312061B1 (it) * | 1999-04-09 | 2002-04-04 | Diapharm Ltd | Sequenza nucleotidica per la rivelazione e caratterizzazione diisolati ospedalieri di hiv-1 che partecipano nei processi di |
JP4307841B2 (ja) | 2001-03-22 | 2009-08-05 | アメリカ合衆国 | グリコシル化抵抗性シアノビリン及び関連コンジュゲート、組成物、核酸、ベクター、宿主細胞、非グリコシル化シアノビリンの製造方法及び使用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU623097B2 (en) * | 1987-10-09 | 1992-05-07 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc |
NL8702403A (nl) * | 1987-10-09 | 1989-05-01 | Stichting Centr Diergeneeskund | Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc. |
JPH04502760A (ja) * | 1988-10-03 | 1992-05-21 | レプリゲン・コーポレーション | エイズの診断,予防および治療に有効な新規hiv蛋白質およびペプチド |
-
1991
- 1991-05-31 JP JP3129224A patent/JPH0570493A/ja not_active Withdrawn
-
1992
- 1992-05-26 AU AU17152/92A patent/AU659839B2/en not_active Ceased
- 1992-05-27 CA CA002069671A patent/CA2069671A1/en not_active Abandoned
- 1992-05-29 AT AT92109072T patent/ATE142262T1/de not_active IP Right Cessation
- 1992-05-29 EP EP92109072A patent/EP0516135B1/de not_active Expired - Lifetime
- 1992-05-29 ES ES92109072T patent/ES2094252T3/es not_active Expired - Lifetime
- 1992-05-29 DE DE69213325T patent/DE69213325T2/de not_active Expired - Fee Related
- 1992-05-29 DK DK92109072.6T patent/DK0516135T3/da active
- 1992-05-30 KR KR1019920009404A patent/KR920021164A/ko not_active Application Discontinuation
-
1996
- 1996-11-14 GR GR960402988T patent/GR3021618T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU659839B2 (en) | 1995-06-01 |
DE69213325D1 (de) | 1996-10-10 |
CA2069671A1 (en) | 1992-12-01 |
EP0516135B1 (de) | 1996-09-04 |
JPH0570493A (ja) | 1993-03-23 |
AU1715292A (en) | 1992-12-17 |
KR920021164A (ko) | 1992-12-18 |
GR3021618T3 (en) | 1997-02-28 |
EP0516135A2 (de) | 1992-12-02 |
EP0516135A3 (en) | 1993-05-05 |
DK0516135T3 (da) | 1996-09-23 |
ES2094252T3 (es) | 1997-01-16 |
DE69213325T2 (de) | 1997-03-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE153536T1 (de) | Hiv-induzierte synzytien blockierender anti-cd-4- antikörper | |
EP2280072A3 (de) | Gruppe B-Streptococcus Antigene | |
CA2143163A1 (en) | Peptides derived from a retrovirus of the hiv group, and their use | |
DK0523395T3 (da) | Seroreaktive områder på proteinerne E1 og E2 i HPV 16 | |
CA2066661A1 (en) | Viral vaccine conjugates | |
ATE142262T1 (de) | Gegen das menschliche immunschwäche-virus gerichtetes immunpräparat | |
EP1375511A3 (de) | Peptide zum Induzieren einer Antwort der zytotoxischen T-Lymphozyten gerichtet gegen das Hepatitis-B-Virus | |
CA2192512A1 (en) | Nm03 antibody materials and methods | |
CA2129747A1 (en) | Peptide for diagnosing and immunizing against t. cruzi infection | |
ES2087111T3 (es) | Vacuna sintetica para la induccion especifica de linfocitos t citotoxicos. | |
AU8010791A (en) | Hiv monoclonal antibody | |
DE3782771D1 (de) | Gegen pseudomonas aeruginosa infektionen wirksame praeparationen und verfahren zu ihrer herstellung. | |
EP0293827A3 (de) | Probe für Leishmaniosis | |
PT91316A (pt) | Processo para a preparacao de vectores recombinantes e de particulas hbsag recombinantes hibridas tendo as caracteristicas morfologicas do antigenio hbsag contendo uma sequencia imunogenica que induz anticorpos neutralizantes dirigidos contra hiv ou susceptivel de ser reconhecida por tais anticorpos | |
ATE109158T1 (de) | Rubella-e1 und c peptide. | |
ES2095258T3 (es) | Nuevo virus de la enfermedad de la bolsa infecciosa. | |
DE69113520D1 (de) | Monoklonale Antikörper gegen HIV GP120. | |
FR2640511B1 (fr) | Medicaments pour le traitement ou la prevention par immunisation passive de l'infection par le virus hiv et procede de preparation | |
BR9711809A (pt) | Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo | |
Lever et al. | Presence of a partially acid‐labile alpha‐interferon in bronchoalveolar lavage fluid of patients with cytomegalovirus pneumonitis is associated with a poor prognosis | |
ATE103817T1 (de) | Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobulin-g-haeltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen. | |
Grundy et al. | Production of a Partially Acid Labile Alpha Interferon in Cytomegalovirus Pneumonitis | |
SE9202318D0 (sv) | Nya peptider, diagnostiska antigen, anvaendning daerav, vacciner och medikamenter | |
Egorenkova et al. | Use of enzyme-immunoassay with Staphylococcus protein A/peroxidase conjugate in serodiagnosis of influenza. | |
Corapi | Bovine viral diarrhea virus: Monoclonal antibody analyses and studies on virus-induced thrombocytopenia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |